Moreover, CBM588 directly induces the release of tumor necrosis factor-related apoptosis-inducing ligands from polymorphonuclear neutrophils, resulting in significant antitumor effects in vitro as well as in in vivo murine bladder cancer models [42]. The gene discussed is TNF; the disease is urinary bladder carcinoma.